These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26180726)

  • 1. High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.
    Lee DE; Trowbridge RM; Ayoub NT; Agrawal DK
    Plast Reconstr Surg Glob Open; 2015 Jun; 3(6):e425. PubMed ID: 26180726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic and keloid scars fail to progress from the CD34
    Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Austin E; Koo E; Jagdeo J
    Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
    Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
    Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatinase activity in keloids and hypertrophic scars.
    Neely AN; Clendening CE; Gardner J; Greenhalgh DG; Warden GD
    Wound Repair Regen; 1999; 7(3):166-71. PubMed ID: 10417752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
    Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
    J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloids, hypertrophic scars, and uterine fibroid development: a prospective ultrasound study of Black and African American women.
    Langton CR; Gerety M; Harmon QE; Baird DD
    F S Sci; 2023 May; 4(2):172-180. PubMed ID: 37028513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Hippo Signaling Pathway and ILK in the Pathophysiology of Human Hypertrophic Scars and Keloids: An Immunohistochemical Investigation.
    Petrou IG; Nikou S; Madduri S; Nifora M; Bravou V; Kalbermatten DF
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.
    Limandjaja GC; Niessen FB; Scheper RJ; Gibbs S
    Exp Dermatol; 2021 Jan; 30(1):146-161. PubMed ID: 32479693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keloids are transcriptionally distinct from normal and hypertrophic scars.
    Walter AS; Stocks M; Akova E; Gauglitz G; Hartmann D; Aszodi A; Böcker W; Saller MM; Volkmer E
    Eur J Dermatol; 2023 Dec; 33(6):604-611. PubMed ID: 38465540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
    Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
    Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for keloids and hypertrophic scars: a review.
    Tosa M; Ogawa R
    Scars Burn Heal; 2020; 6():2059513120932059. PubMed ID: 32655901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
    Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
    J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.